One of the greatest discoveries in modern medicine was made by the British doctor and bacteriologist Alexander Fleming in 1928: penicillin. The development of the manufacturing process in 1943 paved the way for the global fight against diseases. But that was only a partial success. Since then, there has been a race between microbes with antimicrobial resistance and research into new active ingredients. Personalized antibiotic therapy can help solve this problem. Before medication is administered, it determines which antibiotic in which dosage promises the best therapeutic outcome for a patient. To support this process, U.S. company Selux Diagnostics has developed an automated process, supported by the Technology Engineering Center (TEC) from Festo. Selux NGP determines to which antibiotics the pathogen reacts and to which it is resistant. After inoculating the microtiter plates, the laboratory staff place the sample carriers in the analyzer and the system takes care of the rest. Real-life application > www.festo.com/excm > www.festo.com/catalogue/vtoi LifeTech Rapid antibiotic diagnostics
RkJQdWJsaXNoZXIy NzczNDE0